*  Ocular drug delivery
In 1999, prostaglandin-type ophthalmic preparations that require once-a-day administration. During the process of the ... ref Clinical Investigations The ophthalmic rod: A new ophthalmic drug delivery system I Safwat David Alani Graefe's Archive for ... For topical Ocular administration. Wash your hands before use. Pull down the lower lid of the affected eye and apply a small ... stability--in ophthalmic drug delivery stability refers to total product stability not just the chemical stability of a single ...
  http://www.pharmainfo.net/pppc08/ocular-drug-delivery
*  Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles | TVST | ARVO Journals
A) Corneal LE levels post-topical administration of 0.5% LE-CP or LE-MPP. (B) Retinal LE levels post-topical administration of ... Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest ... A) Corneal LE levels post-topical administration of 0.5% LE-CP or LE-MPP. (B) Retinal LE levels post-topical administration of ... A) Corneal LE levels post-topical administration of 0.5% LE-CP or LE-MPP. (B) Retinal LE levels post-topical administration of ...
  http://tvst.arvojournals.org/article.aspx?articleid=2326860
*  Patent US4649047 - Ophthalmic treatment by topical administration of cyclosporin - Google Patents
By requiring systemic administration in cyclosporin treatment of opthalmic diseases not limited to the eye surface, a patient ... The cyclosporin may be topically administered as an ophthalmic drop or ophthalmic ointment containing an effective amount of ... Ophthalmic compositionn and method of using same. US4937078 *. Aug 26, 1988. Jun 26, 1990. Mezei Associates Limited. Liposomal ... Veterinary treatment of ophthalmic disease in animals using toptical tacrolimus. US20040121944 *. Dec 20, 2002. Jun 24, 2004. ...
  http://www.google.com/patents/US4649047?dq=6,332,126
*  Long Term Administration Study of OPC-12759 Ophthalmic Suspension - Full Text View - ClinicalTrials.gov
Long Term Administration Study of OPC-12759 Ophthalmic Suspension. The safety and scientific validity of this study is the ... Long Term Administration Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients. ... Experimental: OPC-12759 Ophthalmic suspension Instillation, 4times/day. Drug: OPC-12759 Ophthalmic suspension Instillation, ... The purpose of this study is to evaluate safety and efficacy of OPC-12759 ophthalmic suspension during 52 weeks in dry eye ...
  https://clinicaltrials.gov/show/NCT00818324
*  Polymyxin B Sulfate eent Monograph for Professionals - Drugs.com
Ophthalmic Administration. In fixed combination with other anti-infectives and corticosteroids, apply topically to the eye as ... Polymyxin B Sulfate Dosage and Administration. Administration. Apply topically to the eye or ear.a b c d e f g h i j k l ... Ophthalmic Ointments. Ophthalmic ointments may delay corneal healing.f k l. Sensitivity Reactions. Hypersensitivity Reactions. ... Bacterial Ophthalmic Infections. Polymyxin B and Neomycin Sulfates and Bacitracin Zinc. Ophthalmic Ointment Apply to the ...
  https://www.drugs.com/monograph/polymyxin-b-sulfate-eent.html
*  Cysteamine Hydrochloride Monograph for Professionals - Drugs.com
Ophthalmic Administration. Apply topically to each eye as an ophthalmic solution; the solution is for topical ophthalmic use ... Pharmacokinetics not evaluated following ophthalmic administration.1 7. Distribution. Extent. Following oral administration, ... Effect of renal impairment on the pharmacokinetics of cysteamine following ophthalmic administration not evaluated because ... Peak concentrations of cysteamine following topical ophthalmic application of the ophthalmic solution not known.1 Because the ...
  https://www.drugs.com/monograph/cysteamine-hydrochloride.html
*  Patent US20110152767 - Method and Apparatus for Drug Delivery - Google Patentsuche
Methods of ophthalmic administration. US6520930 *. 3. Apr. 2001. 18. Febr. 2003. Medrad, Inc.. Injectors, injector systems and ... Ophthalmic Injection Method. US20080097379 *. 26. Sept. 2006. 24. Apr. 2008. Alcon Manufacturing, Ltd.. Ophthalmic injection ... Ophthalmic Injection Device Including Dosage Control Device. US20100057003 *. 9. Okt. 2007. 4. M rz 2010. Cesario Dos Santos. ... Method of Operating Ophthalmic Hand Piece with Disposable End. US20100106089 *. 1. Okt. 2007. 29. Apr. 2010. Cesario Dos Santos ...
  http://www.google.de/patents/US20110152767
*  Patent US4534348 - Instrument for making corneal incisions - Google Patents
Methods of ophthalmic administration. US6397849. Aug 2, 1999. Jun 4, 2002. Insite Vision Incorporated. Methods of ophthalmic ...
  http://www.google.com/patents/US4534348
*  Patent US5911707 - Needle guide - Google Patents
Methods of ophthalmic administration. US6397849. Aug 2, 1999. Jun 4, 2002. Insite Vision Incorporated. Methods of ophthalmic ... administration. US6428560. Feb 19, 2001. Aug 6, 2002. Christopher H. Green. Apparatus for safely removing a needle from a ...
  http://www.google.com/patents/US5911707?dq=7,328,163
*  Patent US8617094 - Fluid infusion methods for glaucoma treatment - Google Patent
Methods of ophthalmic administration. US6413540. 12 sep 2000. 2 jul 2002. Alcon Universal Ltd.. Drug delivery device. ... Ophthalmic device for draining excess intraocular fluid. US5629008. 7 jun 1994. 13 maj 1997. C.R. Bard, Inc.. Method and device ... Method of treating ophthalmic disorders using TGF -β. US5785674. 20 dec 1996. 28 jul 1998. Mateen; Ahmed Abdul. Device and ... Device and method for treating ophthalmic diseases. US6306120. 7 jun 1999. 23 okt 2001. Ben Gee Tan. Applicator and method for ...
  http://www.google.se/patents/US8617094
*  Drug Summary
Ophthalmic Administration. Instruct patient on proper instillation of eye solution.. Do not to touch the tip of the dropper to ... There have been reports that ophthalmic administration of diclofenac may cause increased bleeding of ocular tissues (including ... Ophthalmic Route. Systemic absorption from the ophthalmic formulation is not clinically significant. ... Administration of a CYP2C9 substrate, tolbutamide, on days 1, 4, 8, and 15 with a 3-day regimen of oral aprepitant (125 mg/80 ...
  http://www.pdr.net/drug-summary/Cambia-diclofenac-potassium-2426
*  Drug Summary
Care should be taken to avoid use around the eyes; ophthalmic administration should be avoided. Visual impairment, ocular ... ADMINISTRATION. Topical Administration. Wash hands before and after application. Use gloves if required by universal ... Acne rosacea, acne vulgaris, cataracts, glaucoma, ocular exposure, ophthalmic administration, perioral dermatitis ... Administration of fluocinonide should be limited to the least amount compatible with an effective therapeutic regimen. If ...
  http://www.pdr.net/drug-summary/Vanos-fluocinonide-325
*  Patent US5149320 - Composite anesthetic article and method of use - Google Patents
Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance. ... After the administration of the appropriate treatment the time for the onset of analgesia and the waiting time required before ... Intravenous administration of water soluble analgesic formulations. WO2008079818A3 *. Dec 18, 2007. Sep 12, 2008. Soluprin ... depends on the route and site of administration, the degree of vascularity at the site of infiltration, the pH of the ...
  http://www.google.com/patents/US5149320?dq=6,712,702
*  Zirgan New FDA Drug Approval | CenterWatch
... ganciclovir ophthalmic gel): For the treatment of acute herpetic keratitis. New approved drug details including side effects, ... Zirgan is supplied as a 0.15% gel designed for topical ophthalmic administration. The recommended initial dose is 1 drop in the ... Zirgan (ganciclovir ophthalmic gel). The following drug information is obtained from various newswires, published medical ... Colin J, Hoh HB, Easty DL, Herbort CP, Resnikoff S, Rigal D, Romdane K Ganciclovir ophthalmic gel (Virgan; 0.15%) in the ...
  http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1056/
*  US6033389A - Eye medicament dispensing device - Google Patents
Method for ophthalmic administration of medicament US20060224129A1 (en) * 1998-12-07. 2006-10-05. Beasley Jim C. Septum ... Method for ophthalmic administration of medicament US20070211212A1 (en) * 2002-09-26. 2007-09-13. Percy Bennwik. Eye state ... Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients US8939947B2 (en) 2005-03-04. 2015-01-27. C ... Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients US20080319399A1 (en) * 2007-06-20. 2008-12 ...
  https://patents.google.com/patent/US6033389?oq=6%2C757%2C682
*  Patent US8153162 - Purified amniotic membrane compositions and methods of use - Google Patents
Thus, "ophthalmic administration" encompasses, but is not limited to, intraocular injection, subretinal injection, intravitreal ... The two-step administration regimen may call for sequential administration of the active agents or spaced-apart administration ... ophthalmic solutions, ophthalmic suspensions, ophthalmic ointments, ocular implants and ocular inserts, intraocular solutions, ... Ophthalmic Solution Composition and Treatment of an Eye Disease. An opthalmic eye drop solution is prepared by mixing 100 mg of ...
  http://www.google.com/patents/US8153162?dq=7751826
*  Patent US8586586 - Methods and compositions for treating or preventing erythema - Google Patents
Ratio between Topical Administration Visit and Day 1 (Ophthalmic administration). Day 4/Day 1. 0.3 (0.3, 0.3). 0.3 (0.2, 0.3). ... Ratio between Topical Administration Visit and Day 1 (Ophthalmic administration). Day 4/Day 1. 0.6 (0.4, 0.7). 0.4 (0.3, 0.5). ... 1) Ocular treatment: Administration of brimonidine tartrate 0.2% by ophthalmic route resulted in quantifiable exposure (,10 pg/ ... It has also been discovered that, unlike the topical ophthalmic application, topical administration to an affected skin area a ...
  https://www.google.co.uk/patents/US8586586
*  Akten Gel - FDA prescribing information, side effects and uses
Akten® Ophthalmic Gel, 3.5% contains 35 mg per mL of lidocaine hydrochloride for topical ophthalmic administration. ... ophthalmic anesthetics lidocaine ophthalmic, tetracaine ophthalmic, proparacaine ophthalmic, Alcaine, TetraVisc. Ophthalmic ... Akten® (lidocaine hydrochloride ophthalmic gel) 3.5% is a sterile, preservative-free, single patient use ophthalmic gel ... Akten Gel Dosage and Administration. The recommended dose of Akten® is 2 drops applied to the ocular surface in the area of the ...
  https://www.drugs.com/pro/akten-gel.html
*  Dr. Paul Bascom, Palliative Care, Portland, OR
Inadvertent Ophthalmic Administration of Atropine Drops in a Hospice Patient.. Am J Hosp Palliat Care., Nov (2012) ...
  https://www.healthtap.com/experts/11187904-dr-paul-bascom
*  Patent US20080160017 - Cross-Linked Antibodies - Google Patents
... ophthalmic or rectal administration, or a form suitable for administration by inhalation or insufflation. ... For ophthalmic administration the compounds according to the present invention may be conveniently formulated as microionized ... Alternatively, for ophthalmic administration compounds may be formulated in an ointment such as petrolatum. ... For nasal administration or administration by inhalation, the compounds according to the present invention may be conveniently ...
  http://www.google.com/patents/US20080160017?dq=system+for+measuring+web+traffic
*  Nepafenac (Professional Patient Advice) - Drugs.com
Ophthalmic). Healing of ophthalmic tissue during concomitant administration of ophthalmic products may be delayed. Exceptions: ... ophthalmic anti-inflammatory agents diclofenac ophthalmic, Restasis, ketorolac ophthalmic, cyclosporine ophthalmic, Prolensa, ... flurbiprofen ophthalmic. Postoperative Ocular Inflammation diclofenac ophthalmic, prednisolone ophthalmic, ketorolac ophthalmic ... Administration. For topical ophthalmic use only; shake well prior to use. Remove contact lenses prior to using solutions ...
  https://www.drugs.com/ppa/nepafenac.html
*  Rescula Ophthalmic Solution - FDA prescribing information, side effects and uses
Rescula Ophthalmic Solution official prescribing information for healthcare professionals. Includes: indications, dosage, ... Rescula Ophthalmic Solution Dosage and Administration. The recommended dosage is one drop in the affected eye(s) twice daily. ... ophthalmic glaucoma agents timolol ophthalmic, Lumigan, latanoprost ophthalmic, Travatan, brimonidine ophthalmic, Xalatan ... latanoprost ophthalmic, Travatan, brimonidine ophthalmic, Xalatan, epinephrine ophthalmic, Alphagan, dorzolamide ophthalmic, ...
  https://www.drugs.com/pro/rescula-ophthalmic-solution.html
*  US Patent # 9,370,484. Methods for treating and diagnosing blinding eye diseases - Patents.com
The method of claim 10, wherein the ophthalmic administration is intravitreal or intraocular administration. 12. The method of ... intravitreal or intraocular administration, and/or intravenous administration. Typically, compositions for administration ... In one embodiment, any agent described herein is formulated for ophthalmic administration, including, for example, ... The method of claim 1, wherein the bindarit is formulated for ophthalmic administration. 11. ...
  http://patents.com/us-9370484.html
*  Patent US5206229 - Vitamin d analogues - Google Patents
... polymer systems may also be used to present the active ingredient for both intra-articular and ophthalmic administration. ... Formulations for rectal administration may be in the form of a suppository incorporating the active ingredient and a carrier ... Prevention of ovarian cancer by administration of a Vitamin D compound. US6075015 *. May 27, 1997. Jun 13, 2000. Duphar ... Prevention of ovarian cancer by administration of a Vitamin D compound. US20030119795 *. Nov 21, 2002. Jun 26, 2003. Oregon ...
  http://www.google.com/patents/US5206229?dq=552685
*  Patent US7008960 - Agents for intravitreal administration to treat or prevent disorders of the eye - Google Patents
Hyaluronidase preparation for ophthalmic administration and enzymatic methods for accelerating clearance of hemorrhagic blood ... C. Prior Ophthalmic Applications of Urea and Urea Derivatives:. U.S. Pat. No. 5,629,344 (Charlton et al.) has described the ... Urea opthalmic ointment and solution. US5866120. 22 Nov 1995. 2 Feb 1999. Advanced Corneal Systems, Inc.. Method for ... Urea ophthalmic ointment and solution. US5554187. 18 Aug 1995. 10 Sep 1996. Rizzo, Iii; Joseph. Medication dispensing intra- ...
  http://www.google.com.au/patents/US7008960